Advances in MRD Testing for Informed CRC Treatment : Episode 15
Opinion
Video
CIRCULATE-NORTH AMERICA and Barriers to Enrollment
Author(s):
Stacey Cohen, MD, discusses the rationale and study design of the phase 2/3 CIRCULATE-NORTH AMERICA study evaluating adjuvant chemotherapy selection based on MRD, and the panel discusses barriers to enrollment.
EP: 1.Treating Colorectal Cancer: Overview of MRD Testing and ctDNA
EP: 2.When is MRD Testing Performed in Colorectal Cancer Treatment?
EP: 3.MRD Testing Platforms in Colorectal Cancer
EP: 4.Testing for MRD in Colorectal Cancer
EP: 5.Colorectal Cancer: MRD Testing in the Community Setting
EP: 6.Practical Considerations in MRD Testing in CRC
EP: 7.Evolution of MRD Testing in Colorectal Cancer
EP: 8.Patient Profile: A 52-Year-Old Woman With Colorectal Cancer
EP: 9.Colorectal Cancer: Updates from the GALAXY Arm in CIRCULATE-Japan
EP: 10.BESPOKE CRC: Study of ctDNA-Guided Therapy in Colorectal Cancer
EP: 11.Myths Surrounding Liquid Biopsy and ctDNA Testing for MRD
EP: 12.Patient Profile 2: A 35-Year-Old Man With Oligometastatic Colorectal Cancer
EP: 13.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer
EP: 14.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer: Part 2
Now Viewing
EP: 15.CIRCULATE-NORTH AMERICA and Barriers to Enrollment
EP: 16.MRD Testing in CRC: Gaps in our Understanding and Potential Advancements
EP: 17.Trajectory of CRC Treatment Landscape
Related Videos
Related Content
